Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofVincristine Sulfate Injection from Surat, Gujarat, India. Vincristine SulfateInjection used to treat a number of types of cancer.
Tags: Vincristine Sulfate Injection manufacturer, Vincristine SulfateInjection exporter, Vincristine Sulfate Injection supplier, and Vincristine SulfateInjection, whogmp approved Vincristine Sulfate Injection manufacturer andsupplier, Vincristine Sulfate Injection distributor, Vincristine Sulfate Injectionshipper, Vincristine Sulfate Injection1 mgVincristine Sulfate Injection1 mgsupplier, Vincristine Sulfate Injection 1 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTorCTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceVincristine Sulfate Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Precision Cancer Care SolutionVincristine Sulfate Injection delivers targeted therapy for life-threatening cancers, including acute leukemia and lymphomas. Its preservative-free formulation ensures reduced risk of adverse reactions, providing a reliable choice for oncological protocols.
Strict Safety and Handling MeasuresThis cytotoxic agent requires careful handling by healthcare professionals due to its potent pharmacological effects. Never administer intrathecally as it can cause fatality. The product adheres to rigorous safety, compliance, and packaging standards.
Optimal Shelf Life and StorageMaintain product efficacy by storing Vincristine Sulfate Injection in a cool and dry environment. With a shelf life of up to 2 years, its stability and reliability are assured throughout the period of recommended medical use.
FAQ's of Vincristine Sulfate Injection:
Q: How should Vincristine Sulfate Injection be administered?
A: Vincristine Sulfate Injection is for intravenous use only and must not be administered by any other route, as administration intrathecally is fatal. It should be given by a healthcare professional with experience in cytotoxic chemotherapy.
Q: What conditions is Vincristine Sulfate Injection used to treat?
A: This injection is indicated for the treatment of acute leukemia, Hodgkin's disease, lymphomas, and other malignant disorders. It is prescribed as part of specific chemotherapy regimens by oncologists.
Q: When should Vincristine Sulfate Injection not be used?
A: It must not be used intrathecally. Individuals with known hypersensitivity to vincristine or any formulation component should avoid this product. Use is strictly under prescription by a registered medical practitioner.
Q: Where should Vincristine Sulfate Injection be stored to retain its effectiveness?
A: Store the injection in a cool, dry place as recommended. Proper storage ensures stability and effectiveness of the solution for up to 2 years from the date of manufacture.
Q: What is the process for safe handling and disposal of Vincristine Sulfate Injection?
A: As a cytotoxic agent, Vincristine Sulfate Injection must be handled with protective equipment. Any unused product or waste materials must be disposed of in accordance with local cytotoxic waste regulations to protect handlers and the environment.
Q: What are the benefits of using a preservative-free Vincristine Sulfate Injection?
A: A preservative-free formulation reduces the risk of potential preservative-related side effects, making it safer for patients who are sensitive or require repeated doses during their treatment course.